Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Primary progressive multiple sclerosis

Recruiting

Investigational

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational

Czechia

Participants:18–64 years

Contact Research Centre

Dyslipidaemia

Recruiting

Registered drug

Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Bempedoic Acid

Contact Research Centre

Heart failure with preserved ejection fraction

Recruiting

Registered drug

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Azd5004

Contact Research Centre

Asthma

Recruiting

Investigational

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Investigational

Czechia

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Asthma

Recruiting

Registered drugNo placebo

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Placebo

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Multiple sclerosis

Recruiting

Investigational

Study of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis

Investigational

Czechia

Participants:18–64 years · 65+ years

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

Registered drug

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Progressive multiple sclerosis

Recruiting

Investigational

Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

Investigational

Czechia

Participants:18–64 years
Substances:Vidofludimus Calcium

Contact Research Centre

Anaemia of chronic disease

Recruiting

Registered drugNo placebo

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Darbepoetin Alfa

Contact Research Centre

Cartilage injury+2

Recruiting

InvestigationalNo placebo

Study on the Effectiveness of Lenzumestrocel for Treating Knee Cartilage Defects in Patients

InvestigationalNo placebo

Czechia

Participants:18–64 years
Substances:Lenzumestrocel

Contact Research Centre

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Recruiting

Registered drugNo placebo

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amoxicillin Sodium

Contact Research Centre

Find therapies in clinical trials near you

50 trials match your criteria

Primary progressive multiple sclerosis

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Dyslipidaemia

Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Heart failure with preserved ejection fraction

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Asthma

GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Asthma

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Secondary progressive multiple sclerosis

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Multiple sclerosis

Study of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis

Chronic obstructive pulmonary disease

Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Progressive multiple sclerosis

Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

Anaemia of chronic disease

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Cartilage injury+2

Study on the Effectiveness of Lenzumestrocel for Treating Knee Cartilage Defects in Patients

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.